ASND Insider Trading Activity and SEC Form 4 Filings
ASND insider trading summary
Over the past 12 months, insiders at Ascendis Pharma A/S (ASND) reported 5 open-market purchases worth $610K by 2 insiders and 2 sales worth $4.7M by 2 insiders on SEC Form 4. Net insider selling was $4.1M.
Latest ASND insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Lars Holtug | Insider | Sell | $62K (236 @ $264.13) |
| Aug 14, 2026 | Jean Jacques Bienaime | Insider | Buy | $270K (1,100 @ $245.85) |
| Aug 14, 2026 | Jean Jacques Bienaime | Insider | Buy | $222K (900 @ $246.91) |
| Jun 2, 2026 | Scott Thomas Smith | EVP & Chief Financial Officer | Buy | $22K (100 @ $219.00) |
| May 26, 2026 | Jean Jacques Bienaime | Insider | Buy | $48K (200 @ $239.37) |
| May 26, 2026 | Jean Jacques Bienaime | Insider | Buy | $47K (200 @ $236.24) |
| May 11, 2026 | Flemming Steen Jensen | See Remarks | Sell | $4.6M (19,460 @ $238.49) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.